Glenmark Gets US Regulator's Nod for Oral Contraceptive Drug

New Delhi: Glenmark Pharmaceuticals on Wednesday said it has received final approval from the US Food and Drug Administration (FDA) to sell oral contraceptive tablets in the American market. "Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (the US health regulator) for Drospirenone and Ethinyl Estradiol tablets USP, 3 mg/0.02 mg," the company said in a filing to the ...